Euclidean Capital LLC Insider Profile
4 Followers
Euclidean Capital LLC, Ten Percent Owner at PMV Pharmaceuticals, holds 127.10K shares in PMV Pharmaceuticals (Ticker: PMVP). Most recently, Euclidean Capital LLC Sold 66,396 shares of PMV Pharmaceuticals on Jun 15, 2021 for an estimated value of $2.26M.
Euclidean Capital LLC's Trading History
| PMVPPMV Pharmaceuticals | Jun 15, 2021 | Ten Percent Owner | Informative Sell | 2.26M | $161.42K | |
PMVP Insider Shares: 127.10K (0.28%) | ||||||
You May Also Like
Euclidean Capital LLC insider profile FAQ
What is the percentage of profitable transactions made by Euclidean Capital LLC?
The percentage of profitable transactions made by Euclidean Capital LLC is 100%.
What is the average return per transaction made by Euclidean Capital LLC?
The average return per transaction made by Euclidean Capital LLC is 70.60%.
What stocks does Euclidean Capital LLC hold?
Euclidean Capital LLC holds: PMVP stocks.
What was Euclidean Capital LLC’s latest transaction?
Euclidean Capital LLC’s latest transaction was an Informative Sell of $2.26M.
What was Euclidean Capital LLC's most profitable transaction?
Euclidean Capital LLC’s most profitable transaction was an Informative Sell of PMVP stock on June 11, 2021. The return on the trade was 71.90%.
What is Euclidean Capital LLC's role in PMV Pharmaceuticals?
Euclidean Capital LLC's role in PMV Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
